Neurimmune AG
Identification of novel therapeutics for the treatment of neurodegenerative disorders
Illnesses such as Alzheimer’s and Parkinson’s disease remain as yet incurable. Neurimmune plans to change that by taking an unusual approach. This startup has not investigated the factors that lead to illnesses but rather has focused on those that keep us healthy. The company is applying this knowledge to identify novel therapeutics.
www.neurimmune.com
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
18.10.2024
Positive progress in addressing unmet medical needs (startupticker.ch)
09.04.2024
Clinical success for Neurimmune (startupticker.ch)
02.02.2024
Biogen returns global IP rights on Alzheimer’s drug to Neurimmune (startupticker.ch)
30.05.2023
Positive results for Swiss biotechs’ clinical studies (startupticker.ch)
17.01.2022
Neurimmune and Ono Pharmaceutical collaborate in the field of neurodegenerative diseases (startupticker.ch)
Last Tweets
No milestones
Clinical Operations Manager
Research / Fulltime
The Clinical Operations Manager is a full-time, permanent, on-site role responsible for leading the implementation and management of Phase I to III clinical trials from start-up to close-out. Key responsibilities include defining budgets and timelines, mitigating program risks, ensuring strict GCP and SOP compliance for inspection-readiness, and providing operational input for trial protocols. The manager will also oversee service provider deliverables, coordinate investigator sites, and handle digital trial systems (EDC, IRT, eTMF). The ideal candidate holds a university degree in Life Sciences and brings over 4 years of clinical operations experience within the pharmaceutical industry or a CRO in Europe. Fluent English, excellent communication skills, and a proven track record of independent trial management are required, while US study experience or a background in Regulatory Affairs is highly preferred.
Research Associate
Research / Fulltime
The Research Associate Biomarker Discovery & Bioanalytics is a highly motivated role responsible for developing, validating, and implementing in vitro bioanalytical assays. Key responsibilities include utilizing diverse platforms (such as SIMOA, MSD, and ELISA) to build medium-to-high sensitivity immunoassays, as well as developing immunohistochemical or biochemical assays across multiple matrices like blood, CSF, and tissue. The Associate will perform pharmacokinetic (PK), anti-drug antibody (ADA), and biomarker studies, qualify established assays under GxP guidelines, write SOPs, and support method transfers to internal and external partners. The ideal candidate holds a BSc or MSc in biology, biochemistry, or a related discipline, alongside proven expertise in ligand-binding assay development, troubleshooting, and validation. Strong data-quality focus, independent multi-project management skills, and a good command of English are required.
No videos and documents
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
CTI Start-up Label
CTI Start-up enables entrepreneurs to realize their innovative idea professionally.
In a process of three phases, over forty experienced coaches guide start-up companies on their way to enter the market successfully and attract financing. At the end of the coaching process, the most promising start-up companies have the opportunity to receive the prestigious CTI Start-up ’Label’. In addition, the companies benefit from the wide CTI Start-up network of industry experts, experienced entrepreneurs, business angels, venture capitalists and has access to foundations such as de Vigier, STI, FIT, Gebert, Rüf, etc.
Until today, CTI Start-up reviewed more than 1 800 projects, and awarded over 200 start-up enterprises with the CTI Start-up Label. Over 85% of these companies are still in business and some have shown remarkable growth, which is a sign that CTI Start-up guides them to sustainable success.
CTI also promotes the culture of entrepreneurship at universities, teaching hospitals, technical institutes as well as universities of applied sciences. CTI Entrepreneurship offers workshops to students on how to bring innovation to the market.
Neurimmune AG
Identification of novel therapeutics for the treatment of neurodegenerative disorders
Website:
www.neurimmune.com
Headquarter:
Schlieren
Foundation Date:
November 2006
Technology:
- Biotech
Sectors:
- Vaccines
Support received
